UBS Group
THCA

UBS Group’s Tuscan Holdings Corp. II Common Stock THCA Stock Holding History

UBS Group’s Portfolio THCA Stock Details THCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,973
Closed -$31K – 11834
2022
Q3 		$31K Buy
2,973
+2,073
+230% +$21.5K ﹤0.01% 6865
2022
Q2 		$9K Buy
+900
New +$9.6K ﹤0.01% 8249
2022
Q1 		– Sell
-3,019
Closed -$31K – 11403
2021
Q4 		$31K Buy
3,019
+336
+13% +$3.41K ﹤0.01% 7382
2021
Q3 		$27K Buy
2,683
+411
+18% +$4.13K ﹤0.01% 6874
2021
Q2 		$23K Sell
2,272
-6,752
-75% -$67.7K ﹤0.01% 7211
2021
Q1 		$91K Buy
9,024
+8,436
+1,435% +$89.8K ﹤0.01% 6039
2020
Q4 		$6K Sell
588
-57
-9% -$590 ﹤0.01% 7798
2020
Q3 		$6K Sell
645
-997
-61% -$9.97K ﹤0.01% 7262
2020
Q2 		$17K Sell
1,642
-304
-16% -$3.01K ﹤0.01% 6671
2020
Q1 		$19K Buy
+1,946
New +$19.2K ﹤0.01% 6542

UBS Group's THCA Position: Q4 2022 in Review

UBS Group sold out of Tuscan Holdings Corp. II Common Stock (THCA) in Q4 2022, closing a stake of 2,973 shares — an estimated $31K sold.

UBS Group first reported a position in THCA in Q1 2020 and held it in 10 quarters. The position peaked at $91K in Q1 2021. 0 funds tracked by Wall St. Rank hold THCA as of Q4 2022.

  • UBS Group reported no remaining Tuscan Holdings Corp. II Common Stock position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 2,973 Tuscan Holdings Corp. II Common Stock shares in Q4 2022, an estimated $31K.
  • UBS Group first reported a position in Tuscan Holdings Corp. II Common Stock in Q1 2020 and held it in 10 quarters.
  • UBS Group's Tuscan Holdings Corp. II Common Stock position peaked at $91K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Tuscan Holdings Corp. II Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.